Literature DB >> 6382015

Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.

D M Anderson, M A Dykstra.   

Abstract

Mice were vaccinated with formalin-killed Cryptococcus neoformans either intranasally, intravenously, or intraperitoneally. Resistance to lethal challenge and in vitro phagocytic activity of alveolar and peritoneal macrophages was studied. Increased resistance to lethal challenge was seen following vaccination by each of the three routes but increased phagocytic activity was seen only in alveolar macrophages from mice vaccinated intranasally.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6382015     DOI： 10.1007/bf00441128

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  17 in total

1.  The macrophage as a regulator of lymphocyte function.

Authors:  E R Unanue
Journal:  Hosp Pract       Date:  1979-11

2.  Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.

Authors:  F M LaForce; W J Kelly; G L Huber
Journal:  Am Rev Respir Dis       Date:  1973-10

3.  Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis.

Authors:  I Abrahams
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

4.  Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin.

Authors:  W R Barclay; W M Busey; D W Dalgard; R C Good; B W Janicki; J E Kasik; E Ribi; C E Ulrich; E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1973-03

Review 5.  Phagocytosis of microorganisms.

Authors:  M A Horwitz
Journal:  Rev Infect Dis       Date:  1982 Jan-Feb

6.  Growth of Cryptococcus neoformans within human macrophages in vitro.

Authors:  R D Diamond; J E Bennett
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

7.  Distribution of Cryptococcus neoformans in a natural site.

Authors:  A Ruiz; R A Fromtling; G S Bulmer
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

8.  Candidacidal activity of mouse macrophages in vitro.

Authors:  P K Maiti; R Kumar; L N Mohapatra
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

10.  Specific and non-specific immunity in experimental cryptococcosis in mice.

Authors:  D B LOURIA
Journal:  J Exp Med       Date:  1960-05-01       Impact factor: 14.307
View more
  6 in total

1.  Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii.

Authors:  Tanya Majumder; Min Liu; Vicky Chen; Marife Martinez; Danielle Alvarado; Karl V Clemons; David A Stevens
Journal:  Mycopathologia       Date:  2014-08-15       Impact factor: 2.574

Review 2.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice.

Authors:  S M Muth; J W Murphy
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

5.  CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract.

Authors:  J O Hill
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

6.  Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.

Authors:  Charles A Specht; Chrono K Lee; Haibin Huang; Donald J Tipper; Zu T Shen; Jennifer K Lodge; John Leszyk; Gary R Ostroff; Stuart M Levitz
Journal:  MBio       Date:  2015-12-22       Impact factor: 7.867
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.